Subcutaneous Low-Dose Epoetin Beta for the Avoidance of Transfusion in Patients Scheduled for Elective Surgery Not Eligible for Autologous Blood Donation

This randomized, multicentre, parallel-group study assessed the efficacy of epoetin beta in reducing the transfusion frequency in patients ineligible for autologous blood donation prior to surgery. The patients (n = 194) received either epoetin beta (125 or 250 IU/kg, once weekly) or no therapy for...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European surgical research 2001-09, Vol.33 (5-6), p.303-310
Hauptverfasser:	Wurnig, C., Schatz, K., Noske, H., Hemon, Y., Dahlberg, G., Josefsson, G., Milbrink, J., Hamard, Christiane
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood Transfusion Blood Transfusion, Autologous Blood. Blood coagulation. Reticuloendothelial system Dose-Response Relationship, Drug Erythrocyte Transfusion Erythropoietin - administration & dosage Erythropoietin - therapeutic use Female Hematocrit Hemoglobins - analysis Humans Injections, Subcutaneous Iron - pharmacokinetics Male Medical sciences Original Paper Pharmacology. Drug treatments Postoperative Complications Recombinant Proteins Safety Surgical Procedures, Operative
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!